Bernstein Stands Firm on UnitedHealth: Reiterates Outperform Rating Amid Medicare Advantage Turmoil
Despite recent market turbulence triggered by Medicare Advantage rate announcements, Bernstein reaffirms its confidence in UnitedHealth Group with a $405 price target, even as another major firm adopts a more cautious stance.